Skip to main content
. 2016 Nov 28;68(12):1758–1766. doi: 10.1002/acr.22899

Figure 4.

Figure 4

Mean accumulated sick leave and disability pension days over 7 years for randomized patients as well as for the nonrandomized methotrexate (MTX) responders and their general population comparators. Error bars indicate standard errors. General population: comparators matched 5:1 by age, sex, education level, and place of residence; conventional treatment: sulfasalazine and hydroxychloroquine plus methotrexate; MTX responders: nonrandomized patients who had a favorable Disease Activity Score based on 28‐joint count response to MTX after the run‐in period.